Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol

被引:239
作者
Sharma, SV
Agatsuma, T
Nakano, H
机构
[1] Univ Tennessee, Dept Microbiol & Immunol, Memphis, TN 38163 USA
[2] Kyowa Hakko Kogyo Co Ltd, Tokyo Res Labs, Tokyo 194, Japan
关键词
radicicol; molecular chaperones; transformation suppression; HSP90; Raf;
D O I
10.1038/sj.onc.1201790
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Radicicol, a macrocyclic anti-fungal antibiotic, has the ability to suppress transformation by diverse oncogenes such as Src, Ras and Mos. Despite this useful property, the mechanism by which radicicol exerts its anti-transformation effects is currently unknown, To understand the transformation-suppressing effects of radicicol, a biotinylated derivative of radicicol was chemically synthesized and used as a probe in a Western-blot format to visualize cellular proteins that interact with radicicol, In transformed and untransformed mouse fibroblasts, the most prominent cellular protein that bound to radicicol had a molecular weight of approximately 90 kDa, Further analysis revealed that this protein was the mouse homologue of the 90 kDa heat shock protein (HSP90). This was confirmed by demonstrating the ability of radicicol to specifically bind purified human HSP90, Specificity of binding was demonstrated by the inhibition of binding of biotinylated radicicol by the native drug, Taken together with other studies the present observations suggest that the anti-transformation effects of radicicol may be mediated, at least in part, by the association of radicicol with HSP90 and the consequent dissociation of the Raf/HSP90 complex leading to the attenuation of the Ras/MAP kinase signal transduction pathway.
引用
收藏
页码:2639 / 2645
页数:7
相关论文
共 45 条
  • [11] Signal transduction from multiple Ras effectors
    Katz, ME
    McCormick, F
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1997, 7 (01) : 75 - 79
  • [12] KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923
  • [13] Farnesyltransferase inhibitors: A new class of cancer chemotherapeutics
    Koblan, KS
    Kohl, NE
    Omer, CA
    Anthony, NJ
    Conner, MW
    deSolms, SJ
    Williams, TM
    Graham, SL
    Hartman, GD
    Oliff, A
    Gibbs, JB
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (03) : 688 - 692
  • [14] MORPHOLOGY OF RAS-TRANSFORMED CELLS BECOMES APPARENTLY NORMAL AGAIN WITH TYROSINE KINASE INHIBITORS WITHOUT A DECREASE IN THE RAS-GTP COMPLEX
    KWON, HJ
    YOSHIDA, M
    MUROYA, K
    HATTORI, S
    NISHIDA, E
    FUKUI, Y
    BEPPU, T
    HORINOUCHI, S
    [J]. JOURNAL OF BIOCHEMISTRY, 1995, 118 (01) : 221 - 228
  • [15] KWON HJ, 1992, CANCER RES, V52, P6926
  • [16] KWON HJ, 1992, BIOSCI BIOTECH BIOCH, V56, P538
  • [17] CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4
    LAEMMLI, UK
    [J]. NATURE, 1970, 227 (5259) : 680 - +
  • [18] REQUIREMENT FOR RAS IN RAF ACTIVATION IS OVERCOME BY TARGETING RAF TO THE PLASMA-MEMBRANE
    LEEVERS, SJ
    PATERSON, HF
    MARSHALL, CJ
    [J]. NATURE, 1994, 369 (6479) : 411 - 414
  • [19] Marais R, 1996, CANCER SURV, V27, P101
  • [20] MAP KINASE KINASE KINASE, MAP KINASE KINASE AND MAP KINASE
    MARSHALL, CJ
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) : 82 - 89